Equities researchers at Royal Bank of Canada initiated coverage on shares of athenahealth, Inc. (NASDAQ:ATHN) in a research note issued on Tuesday, MarketBeat reports. The brokerage set a “sector perform” rating and a $153.00 price target on the health services provider’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 23.01% from the stock’s previous close.

A number of other research analysts also recently commented on ATHN. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $154.00 price objective (up previously from $119.00) on shares of athenahealth in a research note on Monday, May 22nd. Dougherty & Co increased their target price on shares of athenahealth from $123.00 to $148.00 and gave the stock a “buy” rating in a research report on Tuesday, May 23rd. Robert W. Baird increased their target price on shares of athenahealth from $140.00 to $160.00 and gave the stock an “outperform” rating in a research report on Thursday, May 25th. UBS AG reissued a “buy” rating and set a $152.00 target price (up previously from $123.00) on shares of athenahealth in a research report on Wednesday, May 31st. Finally, Citigroup Inc. reissued a “buy” rating and set a $163.00 target price (up previously from $128.00) on shares of athenahealth in a research report on Monday, June 5th. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $149.91.

Shares of athenahealth (NASDAQ ATHN) traded down 2.06% during midday trading on Tuesday, hitting $124.38. 485,094 shares of the company’s stock were exchanged. The firm has a market cap of $4.97 billion, a PE ratio of 157.84 and a beta of 1.79. athenahealth has a one year low of $90.11 and a one year high of $158.66. The stock’s 50-day moving average price is $138.24 and its 200 day moving average price is $129.15.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.12. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The company had revenue of $301.10 million during the quarter, compared to the consensus estimate of $298.68 million. During the same quarter in the prior year, the company posted $0.34 EPS. The company’s quarterly revenue was up 15.0% compared to the same quarter last year. Equities research analysts forecast that athenahealth will post $1.91 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/09/19/athenahealth-inc-athn-earns-sector-perform-rating-from-analysts-at-royal-bank-of-canada.html.

In other news, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $130.38, for a total transaction of $39,114.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $140.95, for a total value of $112,760.00. The disclosure for this sale can be found here. Insiders sold 15,722 shares of company stock worth $2,221,721 over the last quarter. 3.20% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in ATHN. Janus Henderson Group PLC acquired a new position in athenahealth during the second quarter worth about $713,856,000. BlackRock Inc. grew its holdings in athenahealth by 30,642.6% during the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after acquiring an additional 1,594,643 shares during the period. Morgan Stanley grew its holdings in athenahealth by 9.7% during the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after acquiring an additional 397,837 shares during the period. Elliott Management Corp acquired a new position in athenahealth during the second quarter worth about $52,706,000. Finally, Clearbridge Investments LLC grew its holdings in athenahealth by 61.8% during the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock worth $102,379,000 after acquiring an additional 347,133 shares during the period.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.